IRB Barcelona opens new laboratory focused on targeted protein degradation as a therapeutic tool

by Parc Científic de Barcelona

Scientist Cristina Mayor-Ruiz joins the Institute for Research in Biomedicine (IRB Barcelona) to lead the new Targeted Protein Degradation and Drug Discovery Lab. Along with the addition of this group...

Read more

Great success of the 13th IBEC Symposium 'Bioengineering for Future & Precision Medicine' ​

by Parc Científic de Barcelona

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, organized from the 27th to the 28th October its 13th Symposium. The event, that this year took place for th...

Read more

A project led by IBMB-CSIC tests molecules that stop the cytokine storm caused by SARS-CoV-2

by Parc Científic de Barcelona

A team of researchers led by Timothy Thomson's group from the Barcelona Institute of Molecular Biology (IBMB-CSIC), based at the Barcelona Science Park, has developed a platform that allows to see i...

Read more

BHV Partners settles in the Barcelona Science Park and closes an investment round of 500,000 euros

by Parc Científic de Barcelona
  • 4 months ago

BHV Partners, the first venture builder in the southern European health sector, has moved its headquarters to the Barcelona Science Park, and closes an investment round, raising half a million euros. ...

Read more

Researchers discover the adhesion mechanism of the bacterium that causes 40% of atypical pneumonias

by Parc Científic de Barcelona

Researchers from Institute of Molecular Biology of Barcelona (IBMB-CSIC) –based in the Barcelona Science Park– and the Institute for Natural Science and Technology at the University of Osaka, ha...

Read more

Queremos Saber VII: El paciente como motor de la innovación

by Parc Científic de Barcelona

Queremos Saber, el ciclo de ponencias de referencia en esclerosis múltiple de la Fundación GAEM y Biocat, ubicadas en el Parc Científic de Barcelona, llega a la séptima edición ampliando sus hori...

Read more

The Barcelona Science Park is committed to becoming Catalonia's MedTech company hub

by Parc Científic de Barcelona

The Barcelona Science Park (PCB), a Spain's leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 ...

Read more

Connecta Therapeutics raises €1.7 M to develop new treatment for fragile X syndrome

by Parc Científic de Barcelona

Connecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...

Read more

New study reveals that women with Covid-19 produce virus-free eggs

by Parc Científic de Barcelona

A study carried out by a team of researchers from Eugin's laboratories in Barcelona, and subsequently published in the scientific journal Human Reproduction, has, for the first time, analysed the eggs...

Read more

Novartis y el Parc Científic de Barcelona lanzan el programa 'Reimagina la Ciencia'

by Parc Científic de Barcelona

Novartis, el Parc Científic de Barcelona (PCB) y Big Van Ciencia han anunciado hoy el lanzamiento del programa “Reimagina la Ciencia: Ensayos Clínicos, investigación y desarrollo de medicamentos

Read more

Alliance between the IMIM and Chemotargets to accelerate the design of new cancer therapies

by Parc Científic de Barcelona

The company Chemotargets –based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform– has signed a strategic agreeme...

Read more

Researchers decipher the structure and mechanism of action of a key complex involved in bacteriophage T7 infection

by Parc Científic de Barcelona

Scientists from the Institute for Research in Biomedicine (IRB Barcelona), at the Barcelona Science Park, and the Spanish National Research Council (CSIC) have combined cryomicroscopy and crystallogra...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Administrar zinc a los pacientes con COV...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Administrar zinc a los pacientes con COVID-19 podría ayudar a su recu...

Photos Stream